[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-340805-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-340805-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","cancer-related-pain-in-head-and-neck-cancer-survivors-longitudinal-findings-from-the-head-and-neck-5000-clinical-cohort","Cancer-related pain in head and neck cancer survivors - longitudinal findings from the Head and Neck 5000 clinical cohort","","Investigates pain trajectories over the first year after diagnosis in head and neck cancer (HNC) survivors using the Head and Neck 5000 longitudinal cohort. Assesses temporal trends and contrasts general versus HN-specific pain across treatment types, disease stages, tumor sites, and HPV status. Identifies patient subgroups with elevated pain risk by combining sociodemographic and clinical variables with patient-reported outcomes collected at baseline, 4, and 12 months. Findings indicate high prevalence and persistent pain in defined risk groups.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/cancer-related-pain-in-head-and-neck-cancer-survivors-longitudinal-findings-from-the-head-and-neck-5000-clinical-cohort/340805/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/cancer-related-pain-in-head-and-neck-cancer-survivors-longitudinal-findings-from-the-head-and-neck-5000-clinical-cohort/340805.png","ImageObject",300,407,{"name":42,"@type":43},"Ophelia","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main purpose of this study?","Question",{"text":63,"@type":64},"To examine how cancer-related pain changes over one year after HNC diagnosis and to compare pain across treatments, stages, sites, and HPV status while identifying high-risk patient subgroups.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was pain measured and when were data collected?",{"text":68,"@type":64},"Patient-reported pain was measured using EORTC QLQ-C30 and QLQ-H&N35, collected at baseline (pre-treatment), and at 4 and 12 months.",{"name":70,"@type":61,"acceptedAnswer":71},"What did the study find about general and HN-specific pain over time?",{"text":72,"@type":64},"Clinically-important general pain increased from 40.9% at baseline to 47.6% at 4 months, then declined to 35.5% at 12 months. HN-specific pain followed a similar pattern in mean scores across the same time points.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},340805,1790472860,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":112,"preview_page_count":33,"preview_urls":145},7971461741311,"https://ap-avatar.wpscdn.com/avatar/74000253aff267980c6?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779345379180704826","Cancer-related pain in head and neck cancer survivors: longitudinal findings from the Head and Neck 5000 clinical cohort  \nIakov Bolnykh1 · Joanne M Patterson2 · Sam Harding3 · Laura-Jayne Watson4 · Liya Lu1,5 · Katrina Hurley6 · Steve J Thomas6 · Linda Sharp1  \nReceived: 14 November 2023 / Accepted: 15 February 2024 / Published online: 29 February 2024 © The Author(s) 2024  \nAbstract  \nPurpose Reports suggest pain is common in head and neck cancer (HNC) . However, past studies are limited by small sample sizes and design and measurement heterogeneity. Using data from the Head and Neck 5000 longitudinal cohort, we investigated pain over a year post-diagnosis. We assessed: temporal trends; compared pain across HNC treatments, stages, sites and by HPV status; and identified subgroups of patients at increased risk of pain.  \nMethods Sociodemographic and clinical data and patient-reported pain (measured by EORTC QLQ-C30 and QLQ-H&N35) were collected at baseline (pre-treatment), 4-and 12-months. Using mixed effects multivariable regression, we investigated time trends and identified associations between (i) clinically-important general pain and (ii) HN-specific pain and clinical, socio-economic, and demographic variables.  \nResults 2,870 patients were included. At baseline, 40.9% had clinically-important general pain, rising to 47.6% at 4-months and declining to 35.5% at 12-months. HN-specific pain followed a similar pattern (mean score (sd): baseline 26.4 (25.10); 4-months. 28.9 (26.55); 12-months, 17.2 (19.83)) . Across time, general and HN-specific pain levels were increased in: younger patients, smokers, and those with depression and comorbidities at baseline, and more advanced, oral cavity and HPV negative cancers.  \nConclusions There is high prevalence of general pain in people living with HNC. We identified subgroups more often reporting general and HN-specific pain towards whom interventions could be targeted.  \nImplications for cancer survivors Greater emphasis should be placed on identifying and treating pain in HNC. Systematic pain screening could help identify those who could benefit from an early pain management plan.  \nKeywords HNC · Pain · HN5000 · Survivorship  \n􀀍 Linda Sharp  \n[linda.sharp@newcastle.ac.uk](linda.sharp@newcastle.ac.uk)[ ](linda.sharp@newcastle.ac.uk)Iakov Bolnykh [iakov.bolnykh@newcastle.ac.uk](iakov.bolnykh@newcastle.ac.uk)[ ](iakov.bolnykh@newcastle.ac.uk)Joanne M Patterson [joanne.patterson@liverpool.ac.uk](joanne.patterson@liverpool.ac.uk)[ ](joanne.patterson@liverpool.ac.uk)Sam Harding [samantha.harding@nbt.nhs.uk](samantha.harding@nbt.nhs.uk)[ ](samantha.harding@nbt.nhs.uk)[Laura-Jayne Watson](Laura-Jayne Watson)[ ](Laura-Jayne Watson)[laura-jayne.watson1@nhs.net](laura-jayne.watson1@nhs.net)  \nLiya Lu  \n[liya.lu@nhs.scot](liya.lu@nhs.scot)  \nKatrina Hurley  \n[katrina.hurley@uhbw.nhs.uk](katrina.hurley@uhbw.nhs.uk)  \nSteve J Thomas  \n[steve.thomas@bristol.ac.uk](steve.thomas@bristol.ac.uk)  \n1 Population Health Sciences Institute, Newcastle University Centre for Cancer, Newcastle, UK  \n2 Liverpool Head and Neck Centre, School of Health Science, University of Liverpool, Liverpool, UK  \n3 Speech and Language Therapy Research Unit, Southmead Hospital North Bristol NHS Hospital Trust, Bristol, UK  \n4 Speech & Language Therapy, Sunderland Royal Hospital, South Tyneside and Sunderland NHS Foundation Trust, Sunderland, UK  \n5 NHS Forth Valley, Stirling, Scotland, UK  \n6 Head & Neck 5000 Study, University Hospitals Bristol and Weston NHS Foundation Trust and University of Bristol, Bristol, UK  \nIntroduction  \nHead and neck cancer (HNC) is the sixth most common cancer worldwide with a range of challenges related to high burden of disease, late presentation, and poor access to care [1, 2] . Rising incidence has been reported internationally, attributed to human papilloma virus (HPV) infection. While HPV-positive tumours most commonly occur in the oropharynx, some oral cavity and larynx cancers are also ","cbCaiaZAqjiOGWF7","https://ap.wps.com/l/cbCaiaZAqjiOGWF7","pdf",1172578,12,"English","# Abstract\n## Purpose and aims\n## Methods\n## Results\n## Conclusions and implications\n# Introduction\n## Background on head and neck cancer and HPV\n## Pain prevalence and biological mechanisms\n## Treatment-related pain and impacts","[{\"question\":\"What is the main purpose of this study?\",\"answer\":\"To examine how cancer-related pain changes over one year after HNC diagnosis and to compare pain across treatments, stages, sites, and HPV status while identifying high-risk patient subgroups.\"},{\"question\":\"How was pain measured and when were data collected?\",\"answer\":\"Patient-reported pain was measured using EORTC QLQ-C30 and QLQ-H\\u0026N35, collected at baseline (pre-treatment), and at 4 and 12 months.\"},{\"question\":\"What did the study find about general and HN-specific pain over time?\",\"answer\":\"Clinically-important general pain increased from 40.9% at baseline to 47.6% at 4 months, then declined to 35.5% at 12 months. HN-specific pain followed a similar pattern in mean scores across the same time points.\"}]","Cancer-related pain in head and neck cancer survivors - longitudinal findings from the Head and Neck 5000 clinical cohort | PDF",1790038954,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/055720f11c7f5a8152413ae25e2abdb1.webp",983,1305,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6fc1299d9a7cb7dd23079395da1d7107.webp",982,1304,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/99904fad79f8fc8e576db41556c783cf.webp",981,1303,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9de9a013540071dcf74df7d950242491.webp",980,1301]